Clinical Laserthermia Systems KUV 2024

Hvad gør Clinical Laserthermia Systems?

Clinical Laserthermia Systems AB (CLS) is a Swedish company that specializes in the development, production, and marketing of medical laser devices. The company was founded in 2008 and is headquartered in Lund, Sweden. CLS's history began with the development of a new method for treating cancer using laser beams. The founders of the company recognized the limited options of conventional tumor treatment methods and decided to develop an innovative technology based on a non-invasive, minimally invasive method of destroying cancer cells using laser beams. CLS's business model is based on the development, production, and marketing of medical laser devices for the treatment of cancer. CLS's products include various types of laser devices for the treatment of tumors in different parts of the body such as the prostate, breast, liver, lung, and other soft tissue tumors. The company also offers training and education for the use of the devices, as well as comprehensive technical support for doctors and medical professionals who use these devices. CLS has various divisions, including the urology division for the treatment of prostate cancer and the tumor division for the treatment of tumors in other parts of the body such as the breast, liver, and lung. CLS's flagship product is the TRANBERG®|Thermal Therapy System. It is an advanced laser device that allows for precise and targeted treatment of tumors by using laser beams to destroy cancer cells while protecting the surrounding tissue and organs. The TRANBERG®|Thermal Therapy System works through a technique called interstitial laser thermotherapy, where laser beams are delivered directly into the tumor through specially designed catheters. The radiation effect leads to the heating of the cancer tissue and ultimately its destruction, while the surrounding tissue remains largely unaffected. CLS's product portfolio also includes the TRANBERG®|Laser Light as an equivalent alternative to traditional tumor surgery. This is an established system that is used in both the diagnosis and treatment of prostate cancer. CLS's target market includes both public and private medical institutions worldwide. The company focuses on markets in Europe, Asia, and North America. In order to meet this goal, the company is present at international conferences and trade fairs and collaborates with global partners and distributors. CLS aims to improve cancer treatment worldwide by developing innovative technologies and solutions that enable more precise, effective, and less invasive treatment of tumors. The company has a clear vision: "To improve lives for cancer patients by making the treatment simpler, more effective, and less invasive." Clinical Laserthermia Systems ist eines der beliebtesten Unternehmen auf Eulerpool.com.